Coronary artery calcium scanning in asymptomatic patients with diabetes mellitus: A paradigm shift

Journal of Diabetes

Volumn 4, Issue 4, 2012, Pages 342-350

  Hecht, Harvey S ^a   Narula, Jagat ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery calcium; Coronary artery disease; Diabetes mellitus

Indexed keywords

CALCIUM;

CARDIOVASCULAR PARAMETERS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIUM; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CALCIUM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; HUMANS; PROGNOSIS; RISK FACTORS; UNITED STATES;

EID: 84870313788     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2012.00212.x     Document Type: Review

References (50)

1. Arad Y, Spadaro LA, Goodman K et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000; 36: 1253-60.
2. Park R, Robert Detrano R, Xiang M et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in non-diabetic individuals. Circulation. 2002; 106: 2073-7.
3. Raggi P, Callister TQ, Cooil B et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron beam computed tomography. Circulation. 2000; 101: 850-5.
4. Wong ND, Hsu JC, Detrano RC et al. Coronary artery calcium evaluation by electron beam compute tomography and its relation to new cardiovascular events. Am J Cardiol. 2000; 86: 495-8.
5. Kondos GT, Hoff JA, Sevrukov A et al. Electron-beam tomography coronary artery calcium and cardiac events: A 37-month follow-up of 5, 635 initially asymptomatic low to intermediate risk adults. Circulation. 2003; 107: 2571-6.
6. Greenland P, LaBree L, Azen SP et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004; 291: 10-8.
7. Shaw LJ, Raggi P, Schisterman E et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all cause mortality. Radiology. 2003; 28: 826-33.
8. Arad Y, Goodman KJ, Roth M et al. Coronary calcification, coronary risk factors, and atherosclerotic cardiovascular disease events. The St Francis Heart Study. J Am Coll Cardiol. 2005; 46: 158-65.
9. Taylor AJ, Bindeman J, Feuerstein I et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors mean three-year outcomes in the prospective army coronary calcium (PACC) project. J Am Coll Cardiol. 2005; 46: 807-14.
10. Vliegenthart R, Oudkerk M, Song B et al. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J. 2002; 23: 1596-603.
11. Budoff MJ, Shaw LJ, Liu ST et al. Long-term prognosis associated with coronary calcification. Observations from a registry of 25253 patients. J Am Coll Cardiol. 2007; 49: 1860-70.
12. Lakoski SG, Greenland P, Wong ND et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score. The multi-ethnic study of atherosclerosis (MESA). Arch Intern Med. 2007; 167: 2437-42.
13. Becker A, Leber A, Becker C, Knez A. Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals. Am Heart J. 2008; 155: 154-60.
14. Detrano R, Guerci AD, Carr JJ et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008; 358: 1336-45.
15. Erbel R, Möhlenkamp S, Moebus S et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis. The Heinz Nixdorf recall study. J Am Coll Cardiol. 2010; 56: 1397-406.
16. Taylor AJ, Fiorillia PN, Hongyan W et al. Relation between the Framingham risk score, coronary calcium, and incident coronary heart disease among low-risk men. Am J Cardiol. 2010; 106: 47-50.
17. Elias-Smale SE, Proença RV, Koller MT et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: The Rotterdam study. J Am Coll Cardiol. 2010; 56: 1407-14.
18. Naghavi M, Falk E, Hecht HS et al. From vulnerable plaque to vulnerable patient. Part III: Executive summary of the screening for heart attack prevention and education (SHAPE) task force report. Am J Cardiol. 2006; 98(Suppl.): 2H-15H.
19. Taylor AJ, Cerqueira M, Hodgson JM et al. Appropriate use criteria for cardiac computed tomography. J Am Coll Cardiol. 2010; 56: 1864-94.
20. Greenland P, Alpert JS, Beller GA et al.2010 ACCF/AHA guideline for assessment of cardiovascular risk in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2010; 56: e50-103.
21. Blaha M, Budoff MJ, Shaw LJ et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging. 2009; 2: 692-700.
22. Sarwar A, Shaw LJ, Shapiro MD et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging. 2009; 2: 675-88.
23. Kalia NK, Miller LG, Nasir K et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006; 185: 394-9.
24. Orakzai RH, Nasir K, Orakzai SH et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008; 101: 999-1002.
25. Schmermund A, Baumgart A, Taylor AJ et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol. 2008; 51: 1337-41.
26. Rozanski A, Gransar H, Shaw LJ et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: The EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011; 57: 1622-32.
27. Raggi P, Cooil B, Shaw LJ et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol. 2003; 92: 827-9.
28. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol. 2004; 24: 1-7.
29. Budoff MJ, Hokanson JE, Nasir K et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging. 2010; 3: 1229-36.
30. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian SimvastatinSurvival Study (4S). Lancet. 1994; 344: 1383-9.
31. Sacks FM, Moyé LA, Davis BR et al. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events Trial. Circulation. 1998; 97: 1446-52.
32. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998; 339: 1349-57.
33. Ridker PM, Danielson E, Fonseca FAH for the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359: 2195-204.
34. Min JK, Lin FY, Gidseg DS et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan. What is the "warranty period for remaining normal". J Am Coll Cardiol. 2010; 55: 1110-7.
35. Diamond GA, Kaul S. The things to come of SHAPE: Cost and effectiveness of cardiovascular prevention. Am J Cardiol. 2007; 99: 1013-5.
36. Haffner SM, Lehto S, Ronnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229-34.
37. Bulagahapatiya U, Siyambalapitiya J, Sithole J, Idri I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysisDiabet Med. 2009; 26: 143-8.
38. Malmberg K, Yusuf S, Gerstein HC et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction. Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000; 102: 1014-9.
39. Executive Summary: Standards of medical care in diabetes-2012. Diabetes Care. 2012; 35(Suppl. 1): 4-10.
40. Young LH, Wackers FJT, Chyun DA et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. JAMA. 2009; 301: 1547-55.
41. Berman DS, Wong ND, Gransar H et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol. 2004; 44: 923-30.
42. Handelsman Y, Mechanick JI, Blonde L et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan. Endocr Prac. 2011; 17(Suppl. 2): 1-53.
43. Wong ND, Sciammarella MG, Polk D et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol. 2003; 41: 1547-53.
44. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004; 43: 1663-9.
45. Becker A, Leber A, Becker B et al. Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: Prospective study in 716 patients over 8 years. BMC Cardiovasc Disord. 2008; 27: 1-8.
46. Elkeles R, Godsland IF, Feher MD et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: The PREDICT study. Eur Heart J. 2008; 29: 2244-51.
47. Anand DV, Lim E, Hopkins D, Corder R et al. Risk stratification in uncomplicated type 2 diabetes: Prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006; 27: 713-21.
48. Malik S, Budoff M, Katz R. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: The Multi-Ethnic Study of Atherosclerosis. Diabetes Care. 2011; 34: 2285-90.
49. Wong ND, Nelson JC, Granston T et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: The Multiethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging. 2012; 5: 358-66.
50. Kiramijyan S, Ahmadi N, Isma'eel H et al. Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes. 2012 (in press).